Elan Holdings, Inc.

Elan Holdings, Inc. — FDA 510(k) Submissions

Elan Holdings, Inc. has submitted 12 FDA 510(k) premarket notifications since 1999, of which 12 received clearance as substantially equivalent to a predicate device.

The company's most frequent device categories include Electrode, Ion Specific, Sodium, Enzymatic Esterase--oxidase, Cholesterol, Urease And Glutamic Dehydrogenase, Urea Nitrogen, Nadh Oxidation/nad Reduction, Ast/sgot, Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes . Use the specialty filter in the sidebar to narrow results.